Abstract
Azo dyes form substantial industrial pollutants owing to their poor biodegradation capacity. Present study identifies azo dye detoxifying strain of bacteria from waste water near textile industries. In order to identify the azo dye degrading strain, 16S rRNA gene was sequenced from the pure bacterial culture obtained from the samples collected from textile industry area at Erode in Tamil Nadu state of India. Two novel azo dye degrading bacteria were found out of 60 samples investigated, which were respectively named Sphingomonas sp strain EMBS022 and Sphingomonas sp strain EMBS023. Isolates of Sphingomonas sp strains - EMBS022 and EMBS023 were deposited in GenBank with accession numbers ‘KF951596’ & ‘KF951597’respectively. UNAFOLD and RNA fold web servers were employed to predict the secondary structure of 16s RNA of these strains. Free energy estimate for secondary structures of 16s rRNA of strains EMBS022 and EMBS023 were ΔG = -159.00 kcal/mol and ΔG = -159.90 kcal/mol, confirming the structures to be considerably stable.
Keywords: Azo dyes degrading bacteria, Sphingomonas species, Sphingomonas sp strain EMBS022 and EMBS023, 16S rRNA gene sequencing.
Current Bioinformatics
Title:Identification of Azo Dye Degrading Sphingomonas Strain EMBS022 and EMBS023 Using 16S rRNA Gene Sequencing
Volume: 10 Issue: 5
Author(s): Anuroopa G. Nadh, Uday Raj Akare, Priya Sharma, Pratibha Yadav, Srinivas Bandaru, Anuraj Nayarisseri and Achuthsankar S. Nair
Affiliation:
Keywords: Azo dyes degrading bacteria, Sphingomonas species, Sphingomonas sp strain EMBS022 and EMBS023, 16S rRNA gene sequencing.
Abstract: Azo dyes form substantial industrial pollutants owing to their poor biodegradation capacity. Present study identifies azo dye detoxifying strain of bacteria from waste water near textile industries. In order to identify the azo dye degrading strain, 16S rRNA gene was sequenced from the pure bacterial culture obtained from the samples collected from textile industry area at Erode in Tamil Nadu state of India. Two novel azo dye degrading bacteria were found out of 60 samples investigated, which were respectively named Sphingomonas sp strain EMBS022 and Sphingomonas sp strain EMBS023. Isolates of Sphingomonas sp strains - EMBS022 and EMBS023 were deposited in GenBank with accession numbers ‘KF951596’ & ‘KF951597’respectively. UNAFOLD and RNA fold web servers were employed to predict the secondary structure of 16s RNA of these strains. Free energy estimate for secondary structures of 16s rRNA of strains EMBS022 and EMBS023 were ΔG = -159.00 kcal/mol and ΔG = -159.90 kcal/mol, confirming the structures to be considerably stable.
Export Options
About this article
Cite this article as:
G. Nadh Anuroopa, Raj Akare Uday, Sharma Priya, Yadav Pratibha, Bandaru Srinivas, Nayarisseri Anuraj and S. Nair Achuthsankar, Identification of Azo Dye Degrading Sphingomonas Strain EMBS022 and EMBS023 Using 16S rRNA Gene Sequencing, Current Bioinformatics 2015; 10 (5) . https://dx.doi.org/10.2174/1574893610666151008012312
DOI https://dx.doi.org/10.2174/1574893610666151008012312 |
Print ISSN 1574-8936 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-392X |

- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Current Perspectives on Novel Drug Delivery Systems and Approaches for Management of Cervical Cancer: A Comprehensive Review
Current Drug Targets Chalcone-Coumarin Derivatives as Potential Anti-Cancer Drugs: An in vitro and in vivo Investigation
Anti-Cancer Agents in Medicinal Chemistry Kinase Inhibitors as Potential Therapeutics for Acute and Chronic Neurodegenerative Conditions
Current Pharmaceutical Design Differential Role of Apoptosis and Autophagy Associated with Anticancer Effect of Lupulone (Hop β-Acid) Derivatives on Prostate Cancer Cells
Anti-Cancer Agents in Medicinal Chemistry Epigenetic Regulation of Cytochrome P450 Enzymes and Clinical Implication
Current Drug Metabolism Cell Contact/Adhesion Proteins Lgl and DFak56: Tumorigenic and Whole-Organism Vital Effects Studied in Drosophila
Anti-Cancer Agents in Medicinal Chemistry Understanding Molecular Pathways and Targets of Brachyury in Epithelial-mesenchymal Transition (EMT) in Human Cancers
Current Cancer Drug Targets LncRNA HOTAIR as Prognostic Circulating Marker and Potential Therapeutic Target in Patients with Tumor Diseases
Current Drug Targets Novel Therapies Against Aggressive and Recurrent Epithelial Cancers by Molecular Targeting Tumor- and Metastasis-Initiating Cells and Their Progenies
Anti-Cancer Agents in Medicinal Chemistry Condition Optimization and Production of Extracellular l-Arginine Deiminase from Vibrio Alginolyticus 1374
Current Biotechnology Novel Triazolyl Berberine Derivatives Prepared via CuAAC Click Chemistry: Synthesis, Anticancer Activity and Structure-Activity Relationships
Anti-Cancer Agents in Medicinal Chemistry Fish and Apoptosis: Studies in Disease and Pharmaceutical Design
Current Pharmaceutical Design Combined Chemotherapy or Biotherapy with Jasmonates: Targeting Energy Metabolism for Cancer Treatment
Current Pharmaceutical Biotechnology Hypomethylation of Urokinase (uPA) Promoter in Breast and Prostate Cancer: Prognostic and Therapeutic Implications
Current Cancer Drug Targets Mitochondria-Targeting Anticancer Metal Complexes
Current Medicinal Chemistry Cholinergic Receptors as Target for Cancer Therapy in a Systems Medicine Perspective
Current Molecular Medicine Epigenetics: Relations to Disease and Laboratory Findings
Current Medicinal Chemistry Short-Chain Fatty Acid Inhibitors of Histone Deacetylases: Promising Anticancer Therapeutics?
Current Cancer Drug Targets MicroRNAs as Diagnostic, Prognostic and Predictive Biomarkers of Cardiac Disease
Recent Patents on Biomarkers Piperine: Medicinal, Analytical and Therapeutics perspective
Current Bioactive Compounds